{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:24:52Z","timestamp":1794219892142,"version":"4.8.0"},"reference-count":45,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Epileptic activity is common throughout the glioma disease course and causes significant morbidity for patients. While its clinical impact on glioma has been analyzed, the underlying biological mechanisms of hyperactivity remain uncharacterized. Herein, the authors characterized the differences in epileptic activity across the disease course of various glioma subtypes based on tumor grade and histopathology. To gain further understanding of potential transcriptional differences between tumor cases presenting with seizures and those with other presentation signs, they analyzed a subset of patients with bulk RNA\u2013sequenced tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors assessed clinical factors associated with glioma-related epilepsy across gliomas: IDH-wildtype glioblastoma (GBM), IDH-mutant astrocytoma, and IDH-mutant oligodendroglioma. They conducted multivariate Cox regression for survival analysis, incorporating variables known to influence glioma patient survival and seizure status. They also utilized bulk RNA sequencing to assess transcriptional correlates of hyperactivity in a subset of the cohort and conducted multivariate logistic regression for seizure presentation using this subgroup\u2019s transcriptional and clinical data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Among 363 gliomas\u2014190 IDH-wildtype GBMs, 113 IDH-mutant astrocytomas, and 60 IDH-mutant oligodendrogliomas\u2014the frequency of seizure as a presenting symptom was assessed. The rate of seizure presentation was significantly lower in IDH-wildtype GBM (30.5%) than in IDH-mutant astrocytoma (56.6%) and IDH-mutant oligodendroglioma (66.7%; p &lt; 0.001) with no difference in seizure at recurrence among the groups. Seizure presentation was associated with smaller-volume tumors and less peritumoral edema in IDH-wildtype GBM (both p &lt; 0.001) and with smaller-volume tumors in IDH-mutant astrocytoma (p = 0.0289). Seizure presentation had lower-grade tumors in IDH-mutant astrocytoma (p = 0.026). When accounting for relevant clinical factors, there was no survival difference between seizure at presentation and seizure at recurrence for any glioma subtype. Transcriptional analysis demonstrated upregulation of pathways related to ion transport and synaptic function in seizure-presenting IDH-wildtype tumors, including specifically\n                      <jats:italic>IGFN1, RELN<\/jats:italic>\n                      , and\n                      <jats:italic>SLC17A8<\/jats:italic>\n                      (VGLUT3). VGLUT3, a vesicular glutamate transporter, was elevated at a protein level for IDH-wildtype GBM presenting with seizures. A multivariate logistic regression for seizure presentation combining clinical and transcriptional variables demonstrated that temporal location (p = 0.032, OR 3.25), parietal location (p = 0.023, OR 5.44), and\n                      <jats:italic>SLC17A8<\/jats:italic>\n                      levels (p = 0.019, OR 3.44) were positively predictive of seizure, whereas the presence of edema (p = 0.004, OR \u22127.57) and\n                      <jats:italic>ADAMTS2<\/jats:italic>\n                      expression (p = 0.015, OR \u22123.46) were both negative predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      In IDH-wildtype GBM, tumors presenting with seizures had smaller volumes than those presenting with other signs. Transcriptionally, seizure presentation in IDH-wildtype GBM correlated with the upregulation of synaptic and ionic pathways, with\n                      <jats:italic>SLC17A8<\/jats:italic>\n                      holding independent predictive value for seizure presentation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2025.11.jns251412","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:45:29Z","timestamp":1775871929000},"page":"157-167","source":"Crossref","is-referenced-by-count":1,"title":["Seizure-presenting IDH-wildtype glioblastoma and the upregulation of a synaptic signature"],"prefix":"10.3171","volume":"145","author":[{"given":"Malcolm F.","family":"McDonald","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"},{"name":"Center for Cancer Neuroscience, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prazwal","family":"Athukuri","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Basit","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Goethe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"English","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Lozzi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akdes Serin","family":"Harmanci","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"},{"name":"Center for Cancer Neuroscience, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash J.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"},{"name":"Center for Cancer Neuroscience, Baylor College of Medicine, Houston;"},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine, Houston; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Deneen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"},{"name":"Center for Cancer Neuroscience, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Mandel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Baylor College of Medicine, Houston;"},{"name":"Center for Cancer Neuroscience, Baylor College of Medicine, Houston;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"2","key":"b1","series-title":"Acta Neurol Scand","first-page":"88","article-title":"Presenting symptoms of glioma in adults","volume":"131","author":"Posti JP","year":"2015","unstructured":"Posti JP, Bori M, Kauko T,  Presenting symptoms of glioma in adults. Acta Neurol Scand. 2015;131(2):88\u201393. doi:10.1111\/ane.12285"},{"issue":"1","key":"b2","series-title":"Neurology","first-page":"e207902","article-title":"Characteristics and prognosis of tumor-related epilepsy during tumor evolution in patients with IDH wild-type glioblastoma","volume":"102","author":"Pallud J","year":"2024","unstructured":"Pallud J, Roux A, Moiraghi A,  Characteristics and prognosis of tumor-related epilepsy during tumor evolution in patients with IDH wild-type glioblastoma. Neurology. 2024;102(1):e207902. doi:10.1212\/WNL.0000000000207902"},{"issue":"267","key":"b3","series-title":"Handb Clin Neurol","first-page":"285","article-title":"Epilepsy and brain tumors","volume":"134","author":"Englot DJ","year":"2016","unstructured":"Englot DJ, Chang EF, Vecht CJ. Epilepsy and brain tumors. Handb Clin Neurol. 2016;134(267):285. doi:10.1016\/B978-0-12-802997-8.00016-5"},{"key":"b4","series-title":"Clin Neurol Neurosurg","first-page":"75","article-title":"Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: a systematic review and meta-analysis","volume":"164","author":"Lu VM","year":"2018","unstructured":"Lu VM, Jue TR, Phan K, McDonald KL. Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2018;164:75\u201380. doi:10.1016\/j.clineuro.2017.11.015"},{"issue":"8","key":"b5","series-title":"Cell","first-page":"1689","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler F","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M,  Cancer neuroscience: state of the field, emerging directions. Cell. 2023;186(8):1689\u20131707. doi:10.1016\/j.cell.2023.02.002"},{"issue":"4","key":"b6","series-title":"Cell","first-page":"803","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh HS","year":"2015","unstructured":"Venkatesh HS, Johung TB, Caretti V,  Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell. 2015;161(4):803\u2013816. doi:10.1016\/j.cell.2015.04.012"},{"issue":"7961","key":"b7","series-title":"Nature","first-page":"599","article-title":"Glioblastoma remodelling of human neural circuits decreases survival","volume":"617","author":"Krishna S","year":"2023","unstructured":"Krishna S, Choudhury A, Keough MB,  Glioblastoma remodelling of human neural circuits decreases survival. Nature. 2023;617(7961):599\u2013607. doi:10.1038\/s41586-023-06036-1"},{"issue":"7971","key":"b8","series-title":"Nature","first-page":"844","article-title":"Remote neuronal activity drives glioma progression through SEMA4F","volume":"619","author":"Huang-Hobbs E","year":"2023","unstructured":"Huang-Hobbs E, Cheng YT, Ko Y,  Remote neuronal activity drives glioma progression through SEMA4F. Nature. 2023;619(7971):844\u2013850. doi:10.1038\/s41586-023-06267-2"},{"issue":"7793","key":"b9","series-title":"Nature","first-page":"166","article-title":"PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis","volume":"578","author":"Yu K","year":"2020","unstructured":"Yu K, Lin CCJ, Hatcher A,  PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis. Nature. 2020;578(7793):166\u2013171. doi:10.1038\/s41586-020-1952-2"},{"issue":"5","key":"b10","series-title":"Neuron","first-page":"682","article-title":"Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation","volume":"111","author":"Curry RN","year":"2023","unstructured":"Curry RN, Aiba I, Meyer J,  Glioma epileptiform activity and progression are driven by IGSF3-mediated potassium dysregulation. Neuron. 2023;111(5):682\u2013695.e9. doi:10.1016\/j.neuron.2023.01.013"},{"issue":"5","key":"b11","series-title":"Neuro Oncol","first-page":"700","article-title":"Prognostic relevance of epilepsy at presentation in glioblastoma patients","volume":"18","author":"Berendsen S","year":"2016","unstructured":"Berendsen S, Varkila M, Kroonen J,  Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro Oncol. 2016;18(5):700\u2013706. doi:10.1093\/neuonc\/nov238"},{"issue":"5","key":"b12","series-title":"Neurosurgery","first-page":"824","article-title":"Improved survival with decreased wait time to surgery in glioblastoma patients presenting with seizure","volume":"81","author":"Flanigan PM","year":"2017","unstructured":"Flanigan PM, Jahangiri A, Kuang R,  Improved survival with decreased wait time to surgery in glioblastoma patients presenting with seizure. Neurosurgery. 2017;81(5):824\u2013833. doi:10.1093\/neuros\/nyx084"},{"key":"b13","series-title":"Epilepsy Behav","first-page":"107307","article-title":"Effect of seizure timing on long-term survival in patients with brain tumor","volume":"111","author":"Wasade VS","year":"2020","unstructured":"Wasade VS, Viarasilpa T, Balki I,  Effect of seizure timing on long-term survival in patients with brain tumor. Epilepsy Behav. 2020;111:107307. doi:10.1016\/j.yebeh.2020.107307"},{"issue":"11","key":"b14","series-title":"Brain","first-page":"3322","article-title":"Survival of brain tumour patients with epilepsy","volume":"144","author":"Mastall M","year":"2021","unstructured":"Mastall M, Wolpert F, Gramatzki D,  Survival of brain tumour patients with epilepsy. Brain. 2021;144(11):3322\u20133327. doi:10.1093\/brain\/awab188"},{"issue":"1","key":"b15","series-title":"J Neurooncol","first-page":"211","article-title":"Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma","volume":"159","author":"Tobochnik S","year":"2022","unstructured":"Tobochnik S, Lapinskas E, Vogelzang J, Ligon KL, Lee JW. Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma. J Neurooncol. 2022;159(1):211\u2013218. doi:10.1007\/s11060-022-04059-8"},{"issue":"10","key":"b16","series-title":"Neuro Oncol","first-page":"1463","article-title":"Role of CX3CR1 signaling in malignant transformation of gliomas","volume":"22","author":"Lee S","year":"2020","unstructured":"Lee S, Latha K, Manyam G, Yang Y, Rao A, Rao G. Role of CX3CR1 signaling in malignant transformation of gliomas. Neuro Oncol. 2020;22(10):1463\u20131473. doi:10.1093\/neuonc\/noaa075"},{"issue":"43","key":"b17","series-title":"Proc Natl Acad Sci U S A","first-page":"15545","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian A","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK,  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201315550. doi:10.1073\/pnas.0506580102"},{"issue":"3","key":"b18","series-title":"Curr Protoc","first-page":"e90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie Z","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV,  Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1(3):e90. doi:10.1002\/cpz1.90"},{"issue":"7","key":"b19","series-title":"Nat Methods","first-page":"676","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin J","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E,  Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u2013682. doi:10.1038\/nmeth.2019"},{"issue":"4","key":"b20","series-title":"J Biol Chem","first-page":"1330","article-title":"Reelin: neurodevelopmental architect and homeostatic regulator of excitatory synapses","volume":"292","author":"Wasser CR","year":"2017","unstructured":"Wasser CR, Herz J. Reelin: neurodevelopmental architect and homeostatic regulator of excitatory synapses. J Biol Chem. 2017;292(4):1330\u20131338. doi:10.1074\/jbc.R116.766782"},{"issue":"1","key":"b21","series-title":"Parkinsons Dis","first-page":"2893662","article-title":"Genome- and exome-wide association studies revealed candidate genes associated with DaTscan imaging features","volume":"2023","author":"Yaghoobi A","year":"2023","unstructured":"Yaghoobi A, Seyedmirzaei H, Ala M. Genome- and exome-wide association studies revealed candidate genes associated with DaTscan imaging features. Parkinsons Dis. 2023;2023(1):2893662. doi:10.1155\/2023\/2893662"},{"issue":"22","key":"b22","series-title":"Proc Natl Acad Sci U S A","first-page":"14488","article-title":"The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate","volume":"99","author":"Fremeau RT","year":"2002","unstructured":"Fremeau RT, Burman J, Qureshi T,  The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A. 2002;99(22):14488\u201314493. doi:10.1073\/pnas.222546799"},{"issue":"2","key":"b23","series-title":"J Neurosurg","first-page":"227","article-title":"Seizure characteristics and control following resection in 332 patients with low-grade gliomas","volume":"108","author":"Chang EF","year":"2008","unstructured":"Chang EF, Potts MB, Keles GE,  Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg. 2008;108(2):227\u2013235. doi:10.3171\/JNS\/2008\/108\/2\/0227"},{"issue":"12","key":"b24","series-title":"Cell","first-page":"2184","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","volume":"185","author":"Varn FS","year":"2022","unstructured":"Varn FS, Johnson KC, Martinek J,  Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. 2022;185(12):2184\u20132199.e16. doi:10.1016\/j.cell.2022.04.038"},{"issue":"3","key":"b25","series-title":"Cancer Cell","first-page":"358","article-title":"Integrated proteogenomic characterization of glioblastoma evolution","volume":"42","author":"Kim KH","year":"2024","unstructured":"Kim KH, Migliozzi S, Koo H,  Integrated proteogenomic characterization of glioblastoma evolution. Cancer Cell. 2024;42(3):358\u2013377.e8. doi:10.1016\/j.ccell.2023.12.015"},{"issue":"3","key":"b26","series-title":"Arch Neurol","first-page":"336","article-title":"Morphological characteristics of brain tumors causing seizures","volume":"67","author":"Lee JW","year":"2010","unstructured":"Lee JW, Wen PY, Hurwitz S,  Morphological characteristics of brain tumors causing seizures. Arch Neurol. 2010;67(3):336\u2013342. doi:10.1001\/archneurol.2010.2"},{"issue":"1","key":"b27","series-title":"Epilepsia","first-page":"149","article-title":"Seizures as presenting symptom in patients with glioblastoma","volume":"60","author":"D\u00fchrsen L","year":"2019","unstructured":"D\u00fchrsen L, Sauvigny T, Ricklefs FL,  Seizures as presenting symptom in patients with glioblastoma. Epilepsia. 2019;60(1):149\u2013154. doi:10.1111\/epi.14615"},{"issue":"11","key":"b28","series-title":"Neuro Oncol","first-page":"1886","article-title":"DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients","volume":"24","author":"Ricklefs FL","year":"2022","unstructured":"Ricklefs FL, Drexler R, Wollmann K,  DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients. Neuro Oncol. 2022;24(11):1886\u20131897. doi:10.1093\/neuonc\/noac108"},{"key":"b29","series-title":"Clin Neurol Neurosurg","first-page":"108911","article-title":"Mapping glioblastoma-induced neurological deficits: a brain atlas","volume":"253","author":"Yun YC","year":"2025","unstructured":"Yun YC, Wolf S, Holz K,  Mapping glioblastoma-induced neurological deficits: a brain atlas. Clin Neurol Neurosurg. 2025;253:108911. doi:10.1016\/j.clineuro.2025.108911"},{"issue":"4","key":"b30","series-title":"Neurosurgery","first-page":"753","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai N","year":"2008","unstructured":"Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753\u2013766. doi:10.1227\/01.neu.0000318159.21731.c."},{"issue":"2","key":"b31","series-title":"J Neurosurg","first-page":"190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix M","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR,  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190\u2013198. doi:10.3171\/jns.2001.95.2.0190"},{"issue":"4","key":"b32","series-title":"J Neurosurg","first-page":"977","article-title":"The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection?","volume":"124","author":"Li YM","year":"2016","unstructured":"Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: can we do better than gross-total resection?. J Neurosurg. 2016;124(4):977\u2013988. doi:10.3171\/2015.5.JNS142087"},{"issue":"1","key":"b33","series-title":"Neurooncol Adv","first-page":"vdaf154","article-title":"Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location","volume":"7","author":"Ferles A","year":"2025","unstructured":"Ferles A, Majewska P, Holden Helland R,  Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location. Neurooncol Adv. 2025;7(1):vdaf154. doi:10.1093\/noajnl\/vdaf154"},{"issue":"7775","key":"b34","series-title":"Nature","first-page":"539","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh HS","year":"2019","unstructured":"Venkatesh HS, Morishita W, Geraghty AC,  Electrical and synaptic integration of glioma into neural circuits. Nature. 2019;573(7775):539\u2013545. doi:10.1038\/s41586-019-1563-y"},{"key":"b35","series-title":"Epilepsy Res","first-page":"106618","article-title":"Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures","volume":"173","author":"Feyissa AM","year":"2021","unstructured":"Feyissa AM, Carrano A, Wang X,  Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures. Epilepsy Res. 2021;173:106618. doi:10.1016\/j.eplepsyres.2021.106618"},{"issue":"289","key":"b36","series-title":"Sci Transl Med","first-page":"289ra86","article-title":"SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma","volume":"7","author":"Robert SM","year":"2015","unstructured":"Robert SM, Buckingham SC, Campbell SL,  SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Sci Transl Med. 2015;7(289):289ra86. doi:10.1126\/scitranslmed.aaa8103"},{"issue":"10","key":"b37","series-title":"Nat Med","first-page":"1269","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham SC","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR,  Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011;17(10):1269\u20131274. doi:10.1038\/nm.2453"},{"issue":"5","key":"b38","series-title":"J Clin Invest","first-page":"2286","article-title":"Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model","volume":"130","author":"Hatcher A","year":"2020","unstructured":"Hatcher A, Yu K, Meyer J, Aiba I, Deneen B, Noebels JL. Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model. J Clin Invest. 2020;130(5):2286\u20132300. doi:10.1172\/JCI133316"},{"issue":"1","key":"b39","series-title":"BMC Cancer","first-page":"82","article-title":"A phase Ib\/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol","volume":"24","author":"Mastall M","year":"2024","unstructured":"Mastall M, Roth P, Bink A,  A phase Ib\/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC Cancer. 2024;24(1):82. doi:10.1186\/s12885-023-11797-z"},{"issue":"9","key":"b40","series-title":"Neuro Oncol","first-page":"1423","article-title":"IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation","volume":"24","author":"Mortazavi A","year":"2022","unstructured":"Mortazavi A, Fayed I, Bachani M,  IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation. Neuro Oncol. 2022;24(9):1423\u20131435. doi:10.1093\/neuonc\/noac003"},{"issue":"7","key":"b41","series-title":"Nat Neurosci","first-page":"956","article-title":"Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling","volume":"25","author":"Kumar P","year":"2022","unstructured":"Kumar P, Lim A, Hazirah SN,  Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling. Nat Neurosci. 2022;25(7):956\u2013966. doi:10.1038\/s41593-022-01095-5"},{"issue":"7","key":"b42","series-title":"J Clin Oncol","first-page":"731","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold C","year":"2016","unstructured":"Happold C, Gorlia T, Chinot O,  Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma. J Clin Oncol. 2016;34(7):731\u2013739. doi:10.1200\/JCO.2015.63.6563"},{"issue":"2","key":"b43","series-title":"Neurology","first-page":"e125","article-title":"Effect of levetiracetam use duration on overall survival of isocitrate dehydrogenase wild-type glioblastoma in adults: an observational study","volume":"98","author":"Pallud J","year":"2022","unstructured":"Pallud J, Huberfeld G, Dezamis E,  Effect of levetiracetam use duration on overall survival of isocitrate dehydrogenase wild-type glioblastoma in adults: an observational study. Neurology. 2022;98(2):e125\u2013e140. doi:10.1212\/WNL.0000000000013005"},{"issue":"10","key":"b44","series-title":"Cell","first-page":"2485","article-title":"Integrative spatial analysis reveals a multi-layered organization of glioblastoma","volume":"187","author":"Greenwald AC","year":"2024","unstructured":"Greenwald AC, Darnell NG, Hoefflin R,  Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell. 2024;187(10):2485\u20132501.e26. doi:10.1016\/j.cell.2024.03.029"},{"issue":"8","key":"b45","series-title":"Cell Rep Med","first-page":"101691","article-title":"The complex molecular epileptogenesis landscape of glioblastoma","volume":"5","author":"Soeung V","year":"2024","unstructured":"Soeung V, Puchalski RB, Noebels JL. The complex molecular epileptogenesis landscape of glioblastoma. Cell Rep Med. 2024;5(8):101691. doi:10.1016\/j.xcrm.2024.101691"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/145\/1\/article-p157.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/145\/1\/article-p157.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/145\/1\/article-p157.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:54:58Z","timestamp":1794218098000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/145\/1\/article-p157.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":45,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2025.11.jns251412","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}